secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0001193125-22-005788
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio reports estimated cash of $765M as of Dec. 31, 2021
----------------------------------------------------------------

- Estimated cash, cash equivalents, and marketable securities of $765M as of December 31, 2021.
- Announcement made via Form 8-K on January 10, 2022.
- No other financial results or forward guidance provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312522005788/0001193125-22-005788-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312522005788/d276640d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-005788

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer